Company Filing History:
Years Active: 2023
Title: Eric Peter Van Der Veer: Innovator in Polyomavirus Research
Introduction
Eric Peter Van Der Veer is a notable inventor based in The Hague, Netherlands. He has made significant contributions to the field of virology, particularly in the study of polyomavirus replication. His innovative work has led to the development of a patent that addresses critical aspects of viral replication.
Latest Patents
Eric Peter Van Der Veer holds a patent titled "Inhibition of polyomavirus replication." This invention relates to antisense molecules and methods for modulating the splicing of polyomavirus T antigen pre-mRNA. The patent describes an antisense oligonucleotide that is 12 to 30 nucleobases in length, preferably between 17 and 20 nucleobases. This oligonucleotide comprises a sequence that is the reverse complement of a contiguous stretch of at least 12 nucleobases of polyomavirus T-antigen pre-mRNA. The invention aims to modulate the splicing of T-antigen pre-mRNA in a cell, providing a potential therapeutic approach to combat polyomavirus infections. Eric has 1 patent to his name.
Career Highlights
Eric Peter Van Der Veer is associated with Academisch Ziekenhuis Leiden, also known as LUMC. His work at this institution has allowed him to collaborate with leading researchers in the field of virology. His dedication to research and innovation has positioned him as a key figure in the study of viral mechanisms.
Collaborations
Throughout his career, Eric has worked alongside esteemed colleagues such as Anton Jan Van Zonneveld and Jurriën Prins. These collaborations have fostered a rich environment for scientific inquiry and innovation.
Conclusion
Eric Peter Van Der Veer's contributions to the field of polyomavirus research exemplify the impact of innovative thinking in addressing complex biological challenges. His patent on the inhibition of polyomavirus replication highlights the importance of ongoing research in virology.